Home Teva Respiratory

Teva Respiratory

In operation
-
New Drug Developer
Basic
Enterprise Profile

Basic Information

Teva Respiratory, a subsidiary of Teva Pharmaceutical Industries, has launched two new products: AirDuo Digihaler and ArmonAir Digihaler, further enhancing its digital inhaler portfolio. Both new inhalers are prescription powder inhalers designed to treat asthma patients aged 12 years and older. AirDuo is used to control asthma symptoms and prevent conditions such as wheezing, while ArmonAir is intended for the long-term treatment of asthma.
Teva Respiratory, LLC
United States of America
unclear
January 01, 2020
--
--

Enterprise Profile

Industrial Sector
New Drug Development
Technology
Sensor
Concept
Department of Preventive Healthcare Disease Prevention Asthma
Application Scenarios
Digital Therapeutics Innovative Drugs Big Data